twolabs.com Open in urlscan Pro
34.67.213.101  Public Scan

Form analysis
1 forms found in the DOM

GET https://twolabs.com

<form class="elementor-search-form" action="https://twolabs.com" method="get">
  <div class="elementor-search-form__toggle" tabindex="0" role="button"> <i aria-hidden="true" class="fas fa-search"></i> <span class="elementor-screen-only">Search</span></div>
  <div class="elementor-search-form__container"> <label class="elementor-screen-only" for="elementor-search-form-ba29d5f">Search</label> <input id="elementor-search-form-ba29d5f" placeholder="Search..." class="elementor-search-form__input"
      type="search" name="s" value="">
    <div class="dialog-lightbox-close-button dialog-close-button" role="button" tabindex="0"> <i aria-hidden="true" class="eicon-close"></i> <span class="elementor-screen-only">Close this search box.</span></div>
  </div>
</form>

Text Content

Skip to content
 * Contact
 * Careers
 * About Us
 * News

 * Contact
 * Careers
 * About Us
 * News

 * Home
 * Services
   * Commercial Launch
   * Compliance
   * Strategic Consulting
   * Medical Affairs & Communications
   * Riparian
   * Market Intelligence
   * Market Access
 * Solutions
   * Post-Launch Optimization
   * Comprehensive REMS Solutions
   * DSCSA Compliance
   * Hub Readiness & Optimization
 * Therapeutic Expertise
   * Cell & Gene
   * Oncology
   * Rare Disease
 * Insights
   * Blog
   * Ebooks
   * Webinars
 * Events

Menu
 * Home
 * Services
   * Commercial Launch
   * Compliance
   * Strategic Consulting
   * Medical Affairs & Communications
   * Riparian
   * Market Intelligence
   * Market Access
 * Solutions
   * Post-Launch Optimization
   * Comprehensive REMS Solutions
   * DSCSA Compliance
   * Hub Readiness & Optimization
 * Therapeutic Expertise
   * Cell & Gene
   * Oncology
   * Rare Disease
 * Insights
   * Blog
   * Ebooks
   * Webinars
 * Events

Search
Search
Close this search box.


COMMERCIAL SOLUTIONS FOR
PHARMA MANUFACTURERS

Two Labs partners with pharmaceutical manufacturers to deliver customized
commercial solutions to help bring their products to market and maintain
compliance across the product lifecycle through industry expertise, integration,
and strategic implementation.

LET'S GET STARTED


PHARMACEUTICAL CONSULTING SERVICES

EXPERIENCED
CONSULTANTS
150 +
PRODUCT LAUNCHES
SUPPORTED
280 +
ACTIVE
CLIENTS
310 +
CLIENTS
RECOMMEND
90 %

Two Labs has supported the launch of 75% of products in the emerging biopharma
market. This gives us an understanding of the landscape that is both broad and
deep, enabling us to build and execute launch plans that are integrated,
thorough, and efficient. 

Emerging pharma is a complex world, but Two Labs’ experience, commitment, and
connections make us the ideal problem-solving partner that can take your launch
plan from an idea to a perfectly executed strategy.


FEATURED SERVICES

BENEFIT FROM DEEP EXPERTISE AND HANDS-ON SUPPORT THROUGHOUT YOUR DRUG'S
LIFECYCLE


Medical Affairs & Communications Strategic Consulting Commercial Launch
Compliance Riparian


MEDICAL AFFAIRS & COMMUNICATIONS

Historically, the only medical affairs & communications solutions available on
the market were built to serve large pharma – until now. Two Labs’ Medical
Affairs & Communications provides vital publication support, strategy, and
scientific services to help small and emerging biopharma and biotech connect
with healthcare providers, patients, payers, and investors.

LEARN MORE >
Medical Strategy

Positioning your drug well in the market starts with getting the language right
early in the development process. We build a plan that is centered around
consistent messaging from the get-go.

Medical Communications

You don’t need to focus energy on making sure there is harmony between the many
moving parts. We promise that your Medical Affairs & Communications services
will be fully integrated with the rest of your launch plan. One strategy,
tailor-made for you.

Publication Planning

From early development to product launch and beyond, we’ll reach your target
healthcare providers, patients, payers, and investors with the information they
need to know about your drug so that it’s top of mind for prescribing and vetted
for covering

Practical Workflow Solutions

Drive efficiency and quality with doDOC’s real-time document collaboration
tools.


STRATEGIC CONSULTING (CEEK)

Our deep bench of experts is able to anticipate your launch plan needs and jump
into the trenches with you to guide the project in real-time so you never miss a
deadline and can avoid preventable losses. From clinical development to medical
affairs to corporate development, we are here to be the practical, integrated,
and interconnected solution your product needs to launch.

LEARN MORE >
Commercial Strategy & Launch Planning

You have a product and a vision but need help building the business that will
bring your launch to life. We have the insight to design your financial model,
investment strategy, brand plan, and commercialization path.

Medical Affairs & Operational Support

Ensuring prescriber visibility starts with defining your message as early as
clinical development. From early phase evidence generation or strategic
publication planning, we can help build the medical affairs strategy that will
carry your product to launch and beyond. 

Program & Portfolio Management

Our team can develop the program framework and dedicated project managers to
augment your team or step in to efficiently execute on the most pressing needs,
whether you need support with an R&D program, an enterprise project, or
portfolio planning.

Organization Optimization

As you grow, it’s essential to keep an eye on the big picture while staying
focused on the launch plan. We can help manage and train your team and optimize
your cross-functional service delivery so that you can keep all your goals on
track.

Corporate Development

Scaling your operations and shifting your priorities are important milestones in
any company’s growth, and there’s no need for them to be intimidating. From
analyzing finances and commercial potential to improving operations, we will
step in to help drive the growth you’re going for.

Clinical Development

From trial design and execution to enrollment planning with a patient-focused
approach, we will support, or even manage, your R&D as you work to translate
your innovative science for clinical practice. 


COMMERCIAL LAUNCH

Our experience launching more than 280 drugs for emerging biopharma
manufacturers means we know that the path to commercialization is anything but
simple. But we’ve found success through our integrated approach, seamlessly
weaving together everything your product needs for a successful launch.

LEARN MORE >
Product Launch

Our team has supported over 280 product launches, giving them the expertise and
experience needed to manage the complex commercialization process.

Trade Management

From DSCSA compliance to data management, we help make sure your product is
efficiently moving through the supply chain so that it can meet the needs of
your patient base.

Specialty Channel Strategy and Implementation

Orphan drugs, cell and gene therapies and other specialty products tend to have
more complexity than retail launches. In addition to our team of specialized
experts, we also offer our partners several additional services, such as
pharmacy network selection, therapy management program design, data
recommendations, and more.

Wholesale/Retail Channel Strategy and Implementation

Distribution, vendor onboarding, data integration, financial modeling, and trade
marketing are critical steps to making sure your product is ready for market.
Two Labs will help you develop your wholesale retail distribution strategy and
manage every element of your execution.

Patient Services and Implementation

From transportation to payment programs, our Patient Services team will remove
your patients’ barriers to access by helping select and manage your suppliers.

Post-Launch Optimization

Even the most comprehensive and sophisticated commercialization strategies need
to evolve in response to fluctuating market dynamics. That’s why our team
provides robust post-launch audits to analyze critical workstreams across
Patient Services, Compendia, Trade & Distribution, and EHRx.


COMPLIANCE

We’ve spent years helping pharma manufacturers of all sizes meet the individual
requirements of different states, mapping out a strategy that ensures your
product has a smooth journey through its various regulatory steps.

LEARN MORE >
State Licensing

Did you know that each of the 50 states has its own licensing requirements for
transporting or dispensing drugs? Our experience navigating these and
connections within each state will keep your strategy on track and help you
avoid fees or lost sales.

State Drug Price Transparency

The regulatory world of Rx drug price reporting is varied and always shifting.
Each state has imposed its own independent reporting requirements, but Two Labs’
dedicated team monitors legislation and maintains your compliance.  

Compendia

Compendia is so much more than a price book. From strategic submissions to
competitive differentiation and data auditing, Two Labs’ Compendia team is
experienced with negotiating new designations to place your drug correctly the
first time.

EHRx Solutions

If a healthcare provider can’t find your drug in the electronic health record,
they can’t prescribe it. With so many EHRs and all of them updating at different
times, you need a partner who is fluent in working with them so that your drug
can achieve HCP visibility as quickly as possible.

Sunshine Transparency & Aggregate Spend

Accordion As the HCP/HCO spend transparency landscape grows in scale and
complexity, so do the reporting requirements for your organization. Our team
supports manufacturers by gathering expenses, aggregating and remediating data,
and preparing and submitting reports within required timeframes to ensure
compliance with federal and state regulations.
Content


RIPARIAN

Our Riparian division is a fully integrated professional services firm providing
consulting services, managed services, and software solutions to the
pharmaceuticals and life sciences industry. We empower our clients by delivering
innovative solutions that provide efficiency, clarity, and accelerated insights
around the government pricing, contracting, and transparency issues that matter
to you.

LEARN MORE >
 * Government Pricing
 * Gross to Net Reporting
 * Bona Fide Service Fee & Fair Market Value Assessments


NEW SOLUTIONS FROM TWO LABS

CUSTOM-BUILT SOLUTIONS FOR COMMON CHALLENGES – ONLY FROM TWO LABS

We provide hub employees with the training and guidance they need to optimize
speed to fill and adherence to support the long-term success of your brand, no
matter how complex your unique therapy may be.

Learn More >

In our experience with over 280 drug launches, even the best strategies need to
evolve. We’ll audit the workstreams that matter to optimize your product’s
continued success.

Learn More >

Manufacturers need to maintain careful payment transparency compliance on an
ongoing basis, and they should begin at least six months prior to launch. We’re
here to help.

Learn More >


THE 0 TO 60 GUIDEBOOK

After 280+ launches, learn how Two Labs helps emerging manufacturers drive
success throughout every step of the commercial journey

DOWNLOAD NOW


INSIGHTS

If you’re looking for impactful best practices or thoughtful analyses on where
the biopharma industry is headed, this is the place for you.

Blogs Webinars

CELL AND GENE THERAPY PIPELINE: NAVIGATING KEY TRENDS AND PRICING DYNAMICS

Read More >

ASEMBIA 2024 UNWRAPPED: INSIGHTS AND KEY TAKEAWAYS

Read More >


EXPERTISE THAT SPANS THE PRODUCT LIFECYCLE

 * Select a phase to learn more.

PRECLINICAL

The pharma commercialization journey begins long before a new drug actually hits
the market. After all, successfully releasing a new drug requires that you have
a thorough understanding of the market and of the competition. It’s the only way
to position your product for optimal results.

Learn More



PRECLINICAL

PHASE I

If your new treatment has been approved to move on to human trials, you’re in a
great position to begin ramping up your efforts. This should also include a
commitment to developing your go to market strategy. However, at this point,
most manufacturers are heavily focused on the trials themselves. After all, if
the trials aren’t a success, there will be no new drug to release to the market.

 

Learn More



PHASE I

PHASE II

Once you’ve moved into Phase II, the likelihood that your drug will be approved
begins to increase substantially. Because of this, it’s a vital time to start
investing resources in your go to market strategy. Hence, at Phase II we begin
to dig deeper into our research, focusing on what’s going to be needed to launch
and sell the new drug, as well as beginning to plan pricing and market access
strategies.

Learn More



PHASE II

PHASE III

The majority of drugs that enter Phase III end up getting approved by the FDA.
While final approval might still be some time away, the near-certainty of
approval warrants manufacturers at Phase III to begin completing the legwork
needed to bring a drug to the market. On top of additional Market Access and
Market Intelligence initiatives, you also need to begin the long list of
Commercialization activities that need completed.

Learn More



PHASE III

LAUNCH

Once you’ve received FDA approval and you’re ready to launch your drug, there’s
a lot of work to be done still, including keeping tabs on the competition and
market landscape, making sure your drug is visible in EHR platforms, and
continuing to track and integrate your data. Of course, there’s also a lot of
legwork involved in managing your inventory, implementing patient support
strategies, and being quick on your feet to identify and resolve issues quickly
as they arise.

Learn More



LAUNCH

GROWTH

As with any product that’s selling on the market, the management of a new drug
is hardly complete once it launches. From continuing to learn about new
developments in the market to quickly resolving issues that arise, there are
plenty of things to keep manufacturers busy with their new treatments. It’s also
vital that you stay on top of any new legal developments so that you don’t risk
losing any of your state licenses.

Learn More



GROWTH

LOSS OF EXCLUSIVITY PLANNING

Once a drug’s patent has expired, it does not mean the end of its profitability.
After all, there are a number of strategies – from maintaining brand equity to
launching your own generic alternative – that could still lead to a significant
amount of revenue.

That said, doing so requires a good amount of insight and planning, including
surveying the market and completing competitive simulations.

Learn More



LOSS OF EXCLUSIVITY PLANNING


CAREERS

Want to work where you can be your best? At Two Labs, we are always looking for
talented, passionate people who have a desire to make a difference with what
they do every day.
Learn more

Through every step of the commercial journey, Two Labs is your partner in
driving success.


SERVICES

 * Commercial Launch
 * Compliance
 * Strategic Consulting
 * Medical Affairs & Communications
 * Riparian
 * Market Intelligence
 * Market Access

 * Commercial Launch
 * Compliance
 * Strategic Consulting
 * Medical Affairs & Communications
 * Riparian
 * Market Intelligence
 * Market Access


SOLUTIONS

 * Post-Launch Optimization
 * REMS Strategy & Program Management
 * DSCSA Compliance

 * Post-Launch Optimization
 * REMS Strategy & Program Management
 * DSCSA Compliance


THERAPEUTIC EXPERTISE

 * Cell & Gene
 * Oncology
 * Rare Disease

 * Cell & Gene
 * Oncology
 * Rare Disease


COMPANY

 * Contact
 * Careers
 * About Us
 * News

 * Contact
 * Careers
 * About Us
 * News


CONTACT INFO

110 Riverbend Avenue, Suite 100
Powell, OH 43065

Phone: (614) 389-4004
Fax: (866) 259-4324
Email: info@twolabs.com

© Copyright 2024 | Powered by PRISM

 * Newsroom
 * Blog
 * Privacy Policy
 * Terms of Use